PLoS ONE (Jan 2022)

Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population.

  • Lidia Cobos-Palacios,
  • María Isabel Ruiz-Moreno,
  • Alberto Vilches-Perez,
  • Antonio Vargas-Candela,
  • Mónica Muñoz-Úbeda,
  • Javier Benítez Porres,
  • Ana Navarro-Sanz,
  • María Dolores Lopez-Carmona,
  • Jaime Sanz-Canovas,
  • Luis M Perez-Belmonte,
  • Juan José Mancebo-Sevilla,
  • Ricardo Gomez-Huelgas,
  • María Rosa Bernal-Lopez

DOI
https://doi.org/10.1371/journal.pone.0265362
Journal volume & issue
Vol. 17, no. 6
p. e0265362

Abstract

Read online

Background and aimsObesity is linked to elevated levels of inflammatory serum markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNFa). Adiponectin and resistin are adipokines related to obesity. It has been described that adipose tissue presents a high production and secretion of these diverse pro-inflammatory molecules, which may have local effects on the physiology of fat cells as well as systemic effects on other organs. Our aim was to evaluate the impact that lifestyle modifications, by following a Mediterranean Diet (MedDiet) program and physical activity (PA) training, would have on inflammatory biomarkers and adipokine profile in a Metabolically Healthy Obese (MHO) elderly population from Malaga (Andalusia, Spain).Subjetcs and methodsSubjects aged ≥65 years (65 to 87 years old) with obesity (BMI ≥30 kg/m2) were included in this study if they met ≤1 of the following criteria: systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥ 85 mmHg; triglycerides ≥150 mg/dL; HDL-C Results166 MHO elderly subjects, 40 (24.1%) male and 126 (75.9%) female (p ConclusionHealthy aging is a multifactorial biological process in which lifestyle is essential. The presence of obesity in elderly metabolically healthy population is not a problem necessarily. Elderly MHO population who eat a MedDiet and practice regularly PA are capable to modulate their production of inflammatory cytokines (CRP, IL-6, TNFa) and adipokines profile (adiponectin, resistin), preventing other metabolic disorders.